Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 25

1.

Safety of meglumine gadoterate (Gd-DOTA)-enhanced MRI compared to unenhanced MRI in patients with chronic kidney disease (RESCUE study).

Deray G, Rouviere O, Bacigalupo L, Maes B, Hannedouche T, Vrtovsnik F, Rigothier C, Billiouw JM, Campioni P, Ferreiros J, Devos D, Alison D, Glowacki F, Boffa JJ, Marti-Bonmati L.

Eur Radiol. 2013 May;23(5):1250-9. doi: 10.1007/s00330-012-2705-x. Epub 2012 Dec 5.

2.

Immunogenicity and safety of an investigational AS02(v)-adjuvanted hepatitis B vaccine in patients with renal insufficiency who failed to respond or to maintain antibody levels after prior vaccination: results of two open, randomized, comparative trials.

Tielemans CL, Vlasak J, Kosa D, Billiouw JM, Verpooten GA, Mezei I, Ryba M, Peeters PC, Mat O, Jadoul MY, Polakovic V, Dhaene M, Treille S, Kuriyakose SO, Leyssen M, Houard SA, Surquin M.

Vaccine. 2011 Feb 1;29(6):1159-66. doi: 10.1016/j.vaccine.2010.12.009. Epub 2010 Dec 16.

PMID:
21167859
3.

Are ACE-inhibitors or ARB's still needed for cardiovascular prevention in high risk patients? Insights from profess and transcend.

Van Mieghem W, Billiouw JM, Brohet C, Dupont AG, Gazagnes MD, Heller F, Krzesinski JM, Missault L, Persu A, Piérard L, Rottiers R, Vanhooren G, Vervaet P, Herman AG.

Acta Clin Belg. 2010 Mar-Apr;65(2):107-14.

PMID:
20491360
4.

Rosuvastatin and cardiovascular events in patients undergoing hemodialysis.

Fellström BC, Jardine AG, Schmieder RE, Holdaas H, Bannister K, Beutler J, Chae DW, Chevaile A, Cobbe SM, Grönhagen-Riska C, De Lima JJ, Lins R, Mayer G, McMahon AW, Parving HH, Remuzzi G, Samuelsson O, Sonkodi S, Sci D, Süleymanlar G, Tsakiris D, Tesar V, Todorov V, Wiecek A, Wüthrich RP, Gottlow M, Johnsson E, Zannad F; AURORA Study Group.

N Engl J Med. 2009 Apr 2;360(14):1395-407. doi: 10.1056/NEJMoa0810177. Epub 2009 Mar 30. Erratum in: N Engl J Med. 2010 Apr 15;362(15):1450.

5.

Lanthanum carbonate treatment, for up to 6 years, is not associated with adverse effects on the liver in patients with chronic kidney disease Stage 5 receiving hemodialysis.

Hutchison AJ, Barnett ME, Krause R, J, Siami GA; Lanthanum Carbonate Study Group.

Clin Nephrol. 2009 Mar;71(3):286-95.

PMID:
19281739
6.

Discovery Belux: comparison of rosuvastatin with atorvastatin in hypercholesterolaemia.

Herregods MC, Daubresse JC, Michel G, Lamotte M, Vissers E, Vandenhoven G; Discovery Belux.

Acta Cardiol. 2008 Aug;63(4):493-9.

PMID:
18795588
7.

Lessons from ONTARGET.

Berlaimont V, Billiouw JM, Brohet C, Dupont AG, Gazagnes MD, Heller F, Krzesinski JM, Missault L, Persu A, Piérard L, Rottiers R, Vanhooren G, Van Mieghem W, Vervaet P, Herman AG.

Acta Clin Belg. 2008 May-Jun;63(3):142-51. Review.

PMID:
18714845
8.

The enigma of hypertensive ESRD: observations on incidence and trends in 18 European, Canadian, and Asian-Pacific populations, 1998 to 2002.

Stewart JH, McCredie MR, Williams SM; Canadian Organ Replacement Register, Fenton SS, Trpeski L; Australia and New Zealand Dialysis and Transplant Registry, McDonald SP; European Renal Association-European Dialysis and Transplant Association Registry, Jager KJ, van Dijk PC; Finnish Registry for Kidney Diseases, Finne P; Swedish Registry for Active Treatment of Uremia, Schon S; Norwegian Renal Registry, Leivestad T; Danish National Registry on Regular Dialysis and Transplantation, Løkkegaard H; Dutch-speaking Belgian Society of Nephrology, Billiouw JM; Austrian Dialysis and Transplant Registry, Kramar R; Basque Renal Patients' Registry, Magaz A; Catalan Renal Registry, Vela E; Valencian Renal Registry, Garcia-Blasco MJ; Hellenic Renal Registry, Ioannidis GA; Malaysian National Renal Registry, Lim YN.

Am J Kidney Dis. 2006 Aug;48(2):183-91.

PMID:
16860183
9.

Biochemical validation of a rat model for polycystic kidney disease: comparison of guanidino compound profile with the human condition.

Torremans A, Marescau B, Kränzlin B, Gretz N, Billiouw JM, Vanholder R, De Smet R, Bouwman K, Brouns R, De Deyn PP.

Kidney Int. 2006 Jun;69(11):2003-12.

PMID:
16641922
10.

Impact of convective flow on phosphorus removal in maintenance hemodialysis patients.

Lornoy W, De Meester J, Becaus I, Billiouw JM, Van Malderen PA, Van Pottelberge M.

J Ren Nutr. 2006 Jan;16(1):47-53.

PMID:
16414441
11.

Lipid and apoprotein changes during atorvastatin up-titration in hemodialysis patients with hypercholesterolemia: a placebo-controlled study.

Lins RL, Matthys KE, Billiouw JM, Dratwa M, Dupont P, Lameire NH, Peeters PC, Stolear JC, Tielemans C, Maes B, Verpooten GA, Ducobu J, Carpentier YA.

Clin Nephrol. 2004 Oct;62(4):287-94.

PMID:
15524059
12.

Re-evaluation and modification of the Stuivenberg Hospital Acute Renal Failure (SHARF) scoring system for the prognosis of acute renal failure: an independent multicentre, prospective study.

Lins RL, Elseviers MM, Daelemans R, Arnouts P, Billiouw JM, Couttenye M, Gheuens E, Rogiers P, Rutsaert R, Van der Niepen P, De Broe ME.

Nephrol Dial Transplant. 2004 Sep;19(9):2282-8. Epub 2004 Jul 20.

13.

The low nanomolar levels of N G-monomethylarginine in serum and urine of patients with chronic renal insufficiency are not significantly different from control levels.

Torremans A, Marescau B, Vanholder R, De Smet R, Billiouw JM, De Deyn PP.

Amino Acids. 2003 Jun;24(4):375-81.

PMID:
12768499
14.

Relationship between nonphenacetin-combined analgesics and nephropathy.

Lornoy W, Becaus I, Billiouw JM, Sierens L.

Kidney Int. 2001 Jun;59(6):2371-2; author reply 2372-3. No abstract available.

15.
16.

Images in clinical medicine. Xanthogranulomatous pyelonephritis.

Van Vlem B, Billiouw JM.

N Engl J Med. 2000 May 25;342(21):1572. No abstract available.

17.

On-line haemodiafiltration. Remarkable removal of beta2-microglobulin. Long-term clinical observations.

Lornoy W, Becaus I, Billiouw JM, Sierens L, Van Malderen P, D'Haenens P.

Nephrol Dial Transplant. 2000;15 Suppl 1:49-54.

18.

Intermittent venovenous haemodiafiltration in critically ill patients with acute renal failure.

Van Malderen P, De Rijck L, Vermaut M, Van Leuven G, De Bolle G, Billiouw JM, Lornoy W, Becaus I.

EDTNA ERCA J. 1998 Oct-Dec;24(4):19-20.

PMID:
10222909
19.

Analgesic nephropathy: clinical features and pathogenesis. Original data on the incidence and prevalence in a single renal unit.

Lornoy W, Becaus I, Billiouw JM, Sierens L.

Acta Clin Belg. 1998 Oct;53(5):311-8. No abstract available.

PMID:
9861755
20.

Remarkable removal of beta-2-microglobulin by on-line hemodiafiltration.

Lornoy W, Becaus I, Billiouw JM, Sierens L, van Malderen P.

Am J Nephrol. 1998;18(2):105-8. Erratum in: Am J Nephrol 2000 Mar-Apr;20(2):168.

PMID:
9569951
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk